Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akesis Pharmaceuticals, a metabolic disease drug development company, has appointed Christos Mantzoros to its scientific advisory board.
Subscribe to our email newsletter
Dr Mantzoros is an associate professor of medicine at Harvard Medical School and an associate professor in epidemiology at the Harvard School of Public Health.
Dr Mantzoros obtained an MD and DSc from the University of Athens Medical School, a Master’s in clinical epidemiology from Harvard School of Public Health and a Master’s in medical sciences from Harvard Medical School.
Carl LeBel, president and COO of Akesis, said: “We are extremely pleased that Christos Mantzoros agreed to join our scientific advisory board. I look forward to interacting with him as we evaluate the potential of AKP-020 in the diabetic setting and as we begin to expand our metabolic disease drug candidate pipeline.”